Search
Posted June 22, 2009 Nationwide Recalls of Dietary Supplement Stamina-Rx Unapproved Ingredient Present in Supplement Food and Drug Administration (FDA) and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all products sold under the name Stamina-Rx. FDA lab analysis found that the product contained the undeclared ingredient − benzamidenafil. Benzamidenafil is in the same therapeutic class…
Read MoreDuring the past decade, there has been a marked increase in the number of reported cases involving counterfeit medicines in developing and developed countries. Particularly, artesunate-based antimalarial drugs have been targeted, because of their high demand and cost. Counterfeit antimalarials can cause death and can contribute to the growing problem of drug resistance, particularly in southeast Asia. In this study,…
Read MoreEarlier this year, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). This legislation indicates that Congress is fbeginning an important journey to address several real threats that substandard and counterfeit drugs pose to the pharmaceutical supply chain.
Read MoreNovo Nordisk product previously reported as stolen in North Carolina has resurfaced recently at a medical center in Houston. Originally posted June 16, 2009 FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not have been stored and handled properly, and…
Read MoreThat is the question that many of our lawmakers are asking. Senators Dorgan (D-ND), Snowe (R-ME), McCain (R-AZ) and Stabenow (D-MI) brought that question to the forefront when they introduced the “Pharmaceutical Market Access and Drug Safety Act of 2009” (S. 525) in March. Currently waiting to be placed on the Senate calendar, the bill would allow for prescription drug importation.
Read More"Counterfeit Drugs Kill" is the slogan the World Health Organization (WHO) uses in its anti-counterfeiting campaign. International organizations, governments of developed and developing countries, and the pharmaceutical industry created the IMPACT initiative (International Medical Products Anti-Counterfeiting Taskforce) to take on the thriving illegal industry that makes profits by selling fake drugs. However, before committing resources, policy makers want to assess…
Read MoreThe cost of counterfeiting is much more than money. In too many cases, counterfeiting costs human health and in some cases lives. For example, a group of clinics in Sierra Leone were closed last week for allegedly administering counterfeit drugs. Other cases involving online drug sellers have claimed the health and lives of patients who bought from illicit Web sites.
Read MoreIt’s happening all the time. Nearly every day, there are new reports of counterfeit drugs flooding the world’s prescription drug market. Just last week, the Partnership for Safe Medicines posted a link about how counterfeit drugs are hastening drug-resistant strains of malaria. And the week before, we shared the news reports out of the United Kingdom about a raid on an Irish counterfeit drug distribution operation and the MHRA’s recall due to possible counterfeit inhalers found in the U.K. supply system.
Read More